Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Collagen biofilm refers to a biomaterial or wound dressing composed of a matrix that incorporates collagen as a primary structural component, often in the form of a hydrogel or scaffold. These products are designed to mimic the extracellular matrix and provide an environment conducive to tissue regeneration and healing. Collagen is the most abundant protein in the human body and plays a critical role in maintaining tissue structure and promoting wound repair. In medical applications, collagen biofilms are used primarily for chronic wound management (such as diabetic ulcers), where they serve both as biocompatible scaffolds for cell migration and proliferation, and as vehicles for sustained delivery of antibiotics or other therapeutics directly to the wound site[5][6][7]. The mechanism of action involves providing structural support for new tissue growth while also potentially disrupting bacterial biofilms by delivering antimicrobial agents locally[4][5]. Collagen’s natural properties—biodegradability, low antigenicity, and ability to attract fibroblasts—make it especially suitable for these uses[6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on collagen biofilm.